GLP1 analogs as treatment of postprandial hypoglycemia following gastric bypass surgery: A potential new indication?

European Journal of Endocrinology

Volumn 169, Issue 6, 2013, Pages 885-889

  Abrahamsson, Niclas ^a   Engström, Britt Edén ^a   Sundbom, Magnus ^b   Karlsson, F Anders ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; DIAZOXIDE; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCOSE; LIRAGLUTIDE; NIFEDIPINE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE BLOOD LEVEL; INCRETIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CLINICAL ARTICLE; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEADACHE; HUMAN; HYPOGLYCEMIA; LOW DRUG DOSE; MEDICAL DOCUMENTATION; NAUSEA; OBSERVATIONAL STUDY; OPEN STUDY; PATIENT SATISFACTION; POSTPRANDIAL HYPOGLYCEMIA; PRESCRIPTION; PRIORITY JOURNAL; RELAPSE; STOMACH BYPASS; STOMACH PAIN; TREATMENT INDICATION; TREATMENT RESPONSE; WEIGHT REDUCTION; ANALOGS AND DERIVATIVES; BLOOD; CASE REPORT; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; MIDDLE AGED; OBESITY, MORBID; POSTPRANDIAL STATE; TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HYPOGLYCEMIA; INCRETINS; MALE; MIDDLE AGED; OBESITY, MORBID; POSTPRANDIAL PERIOD; TREATMENT OUTCOME;

EID: 84888217737     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0504     Document Type: Article

References (24)

1. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K & Schoelles K. Bariatric surgery: a systematic review and meta-analysis. Journal of the American Medical Association 2004 292 1724-1737. (doi:10.1001/jama.292. 14.1724)
2. Cui Y, Elahi D & Andersen DK. Advances in the etiology and management of hyperinsulinemic hypoglycemia after Rouxen-Y gastric bypass. Journal of Gastrointestinal Surgery 2011 15 1879-1888. (doi:10.1007/s11605-011-1585-8)
3. Hammer HF. Medical complications of bariatric surgery: focus on malabsorption and dumping syndrome. Digestive Diseases 2012 30 182-186. (doi:10.1159/000336681)
4. Mine S, Sano T, Tsutsumi K, Murakami Y, Ehara K, Saka M, Hara K, Fukagawa T, Udagawa H & Katai H. Large-scale investigation into dumping syndrome after gastrectomy for gastric cancer. Journal of the American College of Surgeons 2010 211 628-636. (doi:10.1016/j.jamcollsurg.2010.07.003)
5. Marsk R, Jonas E, Rasmussen F & Näslund E. Nationwide cohort study of post-gastric bypass hypoglycaemia including 5, 040 patients undergoing surgery for obesity in 1986-2006 in Sweden. Diabetologia 2010 53 2307-2311. (doi:10.1007/s00125-010-1798-5)
6. Rabiee A, Magruder JT, Salas-Carrillo R, Carlson O, Egan JM, Askin FB, Elahi D & Andersen DK. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the roles of gut hormonal and pancreatic endocrine dysfunction. Journal of Surgical Research 2011 167 199-205. (doi:10.1016/j.jss. 2010. 09.047)
7. Vella A & Service FJ. Incretin hypersecretion in post-gastric bypass hypoglycemia-primary problem or red herring? Journal of Clinical Endocrinology and Metabolism 2007 92 4563-4565. (doi:10.1210/jc.2007-2260)
8. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML & Lloyd RV. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. New England Journal of Medicine 2005 353 249-254. (doi:10.1056/NEJMoa043690)
9. Patti ME, McMahon G, Mun EC, Bitton A, Holst JJ, Goldsmith J, Hanto DW, Callery M, Arky R, Nose V et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 2005 48 2236-2240. (doi:10.1007/s00125-005-1933-x)
10. Meier JJ, Butler AE, Galasso R & Butler PC. Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased b-cell turnover. Diabetes Care 2006 29 1554-1559. (doi:10.2337/dc06-0392)
11. Goldfine AB, Mun EC, Devine E, Bernier R, Baz-Hecht M, Jones DB, Schneider BE, Holst JJ & Patti ME. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. Journal of Clinical Endocrinology and Metabolism 2007 92 4678-4685. (doi:10.1210/jc. 2007-0918)
12. Roslin M, Damani T, Oren J, Andrews R, Yatco E & Shah P. Abnormal glucose tolerance testing following gastric bypass demonstrates reactive hypoglycemia. Surgical Endoscopy 2011 25 1926-1932. (doi:10.1007/s00464-010- 1489-9)
13. McLaughlin T, Peck M, Holst J & Deacon C. Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. Journal of Clinical Endocrinology and Metabolism 2010 95 1851-1855. (doi:10.1210/jc.2009-1628)
14. Montanya E. A comparison of currently available GLP-1 receptor agonists for the treatment of type 2 diabetes. Expert Opinion on Pharmacotherapy 2012 13 1451-1467. (doi:10.1517/14656566. 2012.692777)
15. Holdstock C, Zethelius B, Sundbom M, Karlsson FA & Edén Engström B. Postprandial changes in gut regulatory peptides in gastric bypass patients. International Journal of Obesity 2008 32 1640-1646. (doi:10.1038/ijo.2008.157)
16. Laferrère B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A, Kovack B, Bawa B, Koshy N, Lee H et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2008 93 2479-2485. (doi:10. 1210/jc.2007-2851)
17. Meier JJ, Nauck MA, Pott A, Heinze K, Goetze O, Bulut K, Schmidt WE, Gallwitz B & Holst JJ. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology 2006 130 44-54. (doi:10.1053/j.gastro.2005.10.004)
18. Baggio LL & Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007 132 2131-2157. (doi:10.1053/j.gastro. 2007.03.054)
19. Reubi JC, Perren A, Rehmann R, Waser B, Christ E, Callery M, Goldfine AB & Patti ME. Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass. Diabetologia 2010 53 2641-2645. (doi:10.1007/s00125- 010-1901-y)
20. Lind L, Zethelius B, Sundbom M, Edén Engström B & Karlsson FA. Vasoreactivity is rapidly improved in obese subjects after gastric bypass surgery. International Journal of Obesity 2009 33 1390-1395. (doi:10.1038/ijo.2009.188)
21. Nauck MA, Kleine N, Ørskov C, Holst JJ, Willms B & Creutzfeldt W. Normalization of fasting hyperglyceamia by exogenous glucagonlike peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993 36 741-744. (doi:10.1007/BF00401145)
22. Ahrén B, Schweizer A, Dejager S, Dunning BE, Nilsson PM, Persson M & Foley JE. Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2009 94 1236-1243. (doi:10.1210/jc.2008-2152)
23. Meier JJ, Gethmann A, Gö tze O, Gallwitz B, Holst JJ, Schmidt WE & Nauck MA. Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of nonesterified fatty acids in humans. Diabetologia 2006 49 452-458. (doi:10.1007/s00125-005-0126-y)
24. Halperin F, Patti ME & Goldfine AB. Glucagon treatment for postgastric bypass hypoglycemia. Obesity 2010 18 1858-1860. (doi:10.1038/oby. 2010.15)